Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species

He,Fan; Wang,Qiong; Zheng,Xue-Lian; Yan,Jia-Qi; Yang,Lan; Sun,Hong; Hu,Li-Na; Lin,Yong; Wang,Xia

doi:10.3892/or.2012.1841

Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species

Authors:
- Fan He
- Qiong Wang
- Xue-Lian Zheng
- Jia-Qi Yan
- Lan Yang
- Hong Sun
- Li-Na Hu
- Yong Lin
- Xia Wang
View Affiliations

Affiliations: Laboratory of Molecular and Translational Medicine, Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu 610041, P.R. China
Published online on: May 31, 2012 https://doi.org/10.3892/or.2012.1841
Pages: 601-605

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chemoresistance to cisplatin is a major limitation of cisplatin-based chemotherapy in the clinic. The combination of cisplatin with other agents has been recognized as a promising strategy to overcome cisplatin resistance. Previous studies have shown that wogonin (5,7-dihydroxy-8-methoxyflavone), a flavonoid isolated from the root of the medicinal herb Scutellaria baicalensis Georgi, sensitizes cancer cells to chemotheraputics such as etoposide, adriamycin, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TNF. However, the effect of wogonin on cisplatin-induced cytotoxicity has not been previously reported. In this study, the non-small cell lung cancer cell line A549 and the cervical cancer cell line HeLa were treated with wogonin or cisplatin individually or in combination. It was found for the first time that wogonin is able to sensitize cisplatin-induced apoptosis in both A549 cells and HeLa cells as indicated by the potentiation of activation of caspase-3, and cleavage of the caspase-3 substrate PARP in wogonin and cisplatin co-treated cells. Importantly, wogonin robustly induced H2O2 accumulation in these cells, which substantially contributes to the sensitization of cisplatin cytotoxicity by wogonin, as two reactive oxygen species scavengers, butylated hydroxyanisole (BHA) and N-acetyl-L-cysteine (NAC), significantly suppressed the potentiated cytotoxicity caused by wogonin and cisplatin co-treatment. The results from this study provide important new evidence supporting the potential use of wogonin as a cisplatin sensitizer for cancer therapy.

View Figures

View References

1	Cohen SM and Lippard SJ: Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol. 67:93–130. 2001. View Article : Google Scholar : PubMed/NCBI
2	Siddik ZH: Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 22:7265–7279. 2003. View Article : Google Scholar : PubMed/NCBI
3	Niedner H, Christen R, Lin X, Kondo A and Howell SB: Identification of genes that mediate sensitivity to cisplatin. Mol Pharmacol. 60:1153–1160. 2001.PubMed/NCBI
4	Chi YS, Lim H, Park H and Kim HP: Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol. 66:1271–1278. 2003.PubMed/NCBI
5	Zhao Y, Li H, Gao Z, Gong Y and Xu H: Effects of flavonoids extracted from Scutellaria baicalensis Georgi on hemin-nitrite-H₂O₂ induced liver injury. Eur J Pharmacol. 536:192–199. 2006.PubMed/NCBI
6	Ma SC, Du J, But PP, Deng XL, Zhang YW, Ooi VE, Xu HX, Lee SH and Lee SF: Antiviral chinese medicinal herbs against respiratory syncytial virus. J Ethnopharmacol. 79:205–211. 2002. View Article : Google Scholar : PubMed/NCBI
7	Lee DH, Kim C, Zhang L and Lee YJ: Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. Biochem Pharmacol. 75:2020–2033. 2008. View Article : Google Scholar : PubMed/NCBI
8	Baumann S, Fas SC, Giaisi M, Muller WW, Merling A, Gulow K, Edler L, Krammer PH and Li-Weber M: Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca²⁺-dependent apoptosis. Blood. 111:2354–2363. 2008.PubMed/NCBI
9	Enomoto R, Koshiba C, Suzuki C and Lee E: Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects. Cancer Chemother Pharmacol. 67:1063–1072. 2011. View Article : Google Scholar : PubMed/NCBI
10	Lee E, Enomoto R, Koshiba C and Hirano H: Inhibition of P-glycoprotein by wogonin is involved with the potentiation of etoposide-induced apoptosis in cancer cells. Ann NY Acad Sci. 1171:132–136. 2009. View Article : Google Scholar : PubMed/NCBI
11	Wang HW, Lin CP, Chiu JH, Chow KC, Kuo KT, Lin CS and Wang LS: Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in non-small cell lung cancer cells by wogonin and chrysin. Int J Cancer. 120:2019–2027. 2007. View Article : Google Scholar
12	Lee DH, Rhee JG and Lee YJ: Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin. Br J Pharmacol. 157:1189–1202. 2009. View Article : Google Scholar
13	Yang L, Zheng XL, Sun H, Zhong YJ, Wang Q, He HN, Shi XW, Zhou B, Li JK, Lin Y, et al: Catalase suppression-mediated H(2)O(2) accumulation in cancer cells by wogonin effectively blocks tumor necrosis factor-induced NF-κB activation and sensitizes apoptosis. Cancer Sci. 102:870–876
14	Wang X, Ju W, Renouard J, Aden J, Belinsky SA and Lin Y: 17-Allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-κB pathway. Cancer Res. 66:1089–1095. 2006.PubMed/NCBI
15	Ju W, Wang X, Shi H, Chen W, Belinsky SA and Lin Y: A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-κB pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol. 71:1381–1388. 2007.PubMed/NCBI
16	Fas SC, Baumann S, Zhu JY, Giaisi M, Treiber MK, Mahlknecht U, Krammer PH and Li-Weber M: Wogonin sensitizes resistant malignant cells to TNFα- and TRAIL-induced apoptosis. Blood. 108:3700–3706. 2006.PubMed/NCBI
17	Galati G and O’Brien PJ: Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med. 37:287–303. 2004. View Article : Google Scholar
18	Lin Y, Shi R, Wang X and Shen HM: Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets. 8:634–646. 2008. View Article : Google Scholar : PubMed/NCBI
19	Cao G, Sofic E and Prior RL: Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med. 22:749–760. 1997. View Article : Google Scholar : PubMed/NCBI
20	Sugihara N, Arakawa T, Ohnishi M and Furuno K: Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with α-linolenic acid. Free Radic Biol Med. 27:1313–1323. 1999.PubMed/NCBI
21	Gordaliza M, Garcia PA, del Corral JM, Castro MA and Gomez-Zurita MA: Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon. 44:441–459. 2004.PubMed/NCBI
22	Hildeman DA, Mitchell T, Aronow B, Wojciechowski S, Kappler J and Marrack P: Control of Bcl-2 expression by reactive oxygen species. Proc Natl Acad Sci USA. 100:15035–15040. 2003. View Article : Google Scholar : PubMed/NCBI
23	Wang L, Chanvorachote P, Toledo D, Stehlik C, Mercer RR, Castranova V and Rojanasakul Y: Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells. Mol Pharmacol. 73:119–127. 2008. View Article : Google Scholar : PubMed/NCBI
24	Tenopoulou M, Doulias PT, Barbouti A, Brunk U and Galaris D: Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. Biochem J. 387:703–710. 2005. View Article : Google Scholar : PubMed/NCBI